Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting ReportPreclinical Probes for Oncology

Biodistribution and in-vivo stability of a pet tracer for lung perfusion imaging

Merline Babu, Sneha Mithun, Punita Bhardwaj, Meryl Maria Vilangattil, Kinnari Chitnis, Niha Nisar, Ashish Jha, Amit Nautiyal, Bhabani Mohanty, Pradip Chaudhari, Rakhee Vatsa, Mythili Kameswaran and VENKATESH RANGARAJAN
Journal of Nuclear Medicine August 2022, 63 (supplement 2) 2886;
Merline Babu
1Tata Memorial Hospital
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sneha Mithun
1Tata Memorial Hospital
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Punita Bhardwaj
1Tata Memorial Hospital
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Meryl Maria Vilangattil
2Tata Memorial Hospital, Mumbai
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kinnari Chitnis
1Tata Memorial Hospital
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Niha Nisar
1Tata Memorial Hospital
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ashish Jha
1Tata Memorial Hospital
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Amit Nautiyal
3Advanced Centre for Treatment, Research and Education in Cancer (ACTREC), Navi Mumbai
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Bhabani Mohanty
4Advanced Centre for Treatment, Research and Education in Cancer
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Pradip Chaudhari
5ACTREC
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rakhee Vatsa
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mythili Kameswaran
1Tata Memorial Hospital
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
VENKATESH RANGARAJAN
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
Loading

Abstract

2886

Introduction: 99mTc-Macroaggregated Albumin (MAA) is conventionally used for lung perfusion study using SPECT scanner. Earlier, in-house synthesis of Ga-MAA in hospital radiopharmacy has been reported. To assess the suitability of 68Ga-MAA as a PET lung perfusion agent, its normal biodistribution and in-vivo stability in swiss mice and Sprague Dawley rats are reported in the present study.

Methods: This study has been approved by the institutional animal ethics committee. Commercially available lyophilized MAA kits and eluate from 68Ge/68Ga generator were used. The macroaggregates were extracted and radiolabelled as per the previously standardized procedure. Radiochemical purity(RCP) of the preparation was determined using the TLC method. 68Ga-MAA (~100 µCi) was injected via the lateral tail vein. Biodistribution was performed in swiss mice and sprague dawley rats. Animals were sacrificed at 10 min, 30 min and 2 h post administration. Prior to the sacrifice, blood was collected from the retro-orbital vein of each animal. The animals were dissected and organs removed and counted in a well counter. The percentage Injected Dose (% ID) was determined for each organ. Imaging was also performed in mice using animal PET scanner at same time points after administration of 100 µCi of tracer.

Results: The average radiochemical yield and RCP of preparation was observed to be >95% and >99%, respectively. The %ID for each organ at different time points was shown in table. The average maximum and minimum % injected dose (ID) across all the time points in both mice and rats were noted to be > 90 % in lungs and <1 % in blood, liver and kidney. The animal imaging study also qualitatively corroborates with the findings of biodistribution study (figure).

Table: Biodistribution of 68Ga-MAA in Swiss Mice & Sprague Dawley Rats

Conclusions: Our results show that maximum uptake of the tracer was in the lungs with uniform distribution which is consistent with earlier published literature. The percentage uptake in the lung remains same for upto 2 h with no significant leaching indicating good in-vivo stability for upto 2 h post injection.

Figure
  • Download figure
  • Open in new tab
  • Download powerpoint
Previous
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 63, Issue supplement 2
August 1, 2022
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Biodistribution and in-vivo stability of a pet tracer for lung perfusion imaging
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Biodistribution and in-vivo stability of a pet tracer for lung perfusion imaging
Merline Babu, Sneha Mithun, Punita Bhardwaj, Meryl Maria Vilangattil, Kinnari Chitnis, Niha Nisar, Ashish Jha, Amit Nautiyal, Bhabani Mohanty, Pradip Chaudhari, Rakhee Vatsa, Mythili Kameswaran, VENKATESH RANGARAJAN
Journal of Nuclear Medicine Aug 2022, 63 (supplement 2) 2886;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Biodistribution and in-vivo stability of a pet tracer for lung perfusion imaging
Merline Babu, Sneha Mithun, Punita Bhardwaj, Meryl Maria Vilangattil, Kinnari Chitnis, Niha Nisar, Ashish Jha, Amit Nautiyal, Bhabani Mohanty, Pradip Chaudhari, Rakhee Vatsa, Mythili Kameswaran, VENKATESH RANGARAJAN
Journal of Nuclear Medicine Aug 2022, 63 (supplement 2) 2886;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Figures & Data
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Evaluation of 99MTc-HYNIC-PSMA avidity in subtypes of renal cell carcinoma tumors based on histopathologic results
  • Synthesis and Evaluation of 68Ga-NOTA-ADG as a Novel PET Probe for Tumor Imaging
  • <Sup>177</Sup>Lu melanoma therapy with a novel, metabolically stabilized MC1R-targeting ligand in a human melanoma model
Show more Preclinical Probes for Oncology

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire